AchilleS Vaccines
Achilles Vaccines Srl belongs to the long tradition of Siena in the field of vaccines and biotech and aims at playing a prominent role in the development and production of innovative vaccines thanks to two revolutionary, versatile and very efficient technology platforms, able to produce different kinds of vaccines with specific target and low costs.
The procedures and the employed working methods, also based on big data and deep learning approaches, as well as on cooperations with the most important and successful operators in the field, assure very high level performances and a partial dematerialisation and delocalisation of development and production. All these aspects make the company extremely dynamic and able to face the changes of the market in a flexible and functioning way.
At the moment Achilles Vaccines is developing some promising vaccines able to defeat some global health emergencies such as the antibiotic resistance and never disappeared pandemic diseases such as malaria.
Achilles Vaccines is incubated in TLS since 2018.
